Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Antiphospholipid Syndrome (APS)
Bullous Pemphigoid (BP)
Behçet's Syndrome (BS)
Dermatomyositis (DM)
Immune-mediated Necrotizing Myopathy (IMNM)
Immune Thrombocytopenia (ITP)

Interventions

DRUG: RAY121

Sponsor

Chugai Pharmaceutical